Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial.

ABSTRACT:

SUBMITTER: Sohn GK 

PROVIDER: S-EPMC6659355 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature